WO2004081206A3 - Nouveaux polypeptides codes par des genes bacteriens essentiels - Google Patents

Nouveaux polypeptides codes par des genes bacteriens essentiels Download PDF

Info

Publication number
WO2004081206A3
WO2004081206A3 PCT/CA2004/000362 CA2004000362W WO2004081206A3 WO 2004081206 A3 WO2004081206 A3 WO 2004081206A3 CA 2004000362 W CA2004000362 W CA 2004000362W WO 2004081206 A3 WO2004081206 A3 WO 2004081206A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides encoded
novel polypeptides
bacterial genes
essential bacterial
essential
Prior art date
Application number
PCT/CA2004/000362
Other languages
English (en)
Other versions
WO2004081206A2 (fr
Inventor
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Rosanne Thalakada
Cheryl Arrowsmith
Hui Ouyang
Megan Domagala
Cristina Virag
Bryan Beattie
Kamran Mansoury
Veronica Canadien
Dawn Richards
Ivy Ng
Kathleen Nethery
Simon Houston
Kristina Buzadzija
Matthew Tai
Dhushy Kanagarajah
Kamaljit Boora
Muhammad Zahoor Alam
Original Assignee
Affinium Pharm Inc
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Rosanne Thalakada
Cheryl Arrowsmith
Hui Ouyang
Megan Domagala
Cristina Virag
Bryan Beattie
Kamran Mansoury
Veronica Canadien
Dawn Richards
Ivy Ng
Kathleen Nethery
Simon Houston
Kristina Buzadzija
Matthew Tai
Dhushy Kanagarajah
Kamaljit Boora
Muhammad Zahoor Alam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharm Inc, Aled Edwards, Akil Dharamsi, Masoud Vedadi, Rosanne Thalakada, Cheryl Arrowsmith, Hui Ouyang, Megan Domagala, Cristina Virag, Bryan Beattie, Kamran Mansoury, Veronica Canadien, Dawn Richards, Ivy Ng, Kathleen Nethery, Simon Houston, Kristina Buzadzija, Matthew Tai, Dhushy Kanagarajah, Kamaljit Boora, Muhammad Zahoor Alam filed Critical Affinium Pharm Inc
Publication of WO2004081206A2 publication Critical patent/WO2004081206A2/fr
Publication of WO2004081206A3 publication Critical patent/WO2004081206A3/fr
Priority to US11/167,924 priority Critical patent/US20070072192A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des cibles polypeptidiques destinées à des bactéries pathogènes. L'invention concerne également des caractéristiques biochimiques et biophysiques desdits polypeptides.
PCT/CA2004/000362 2002-12-26 2004-03-12 Nouveaux polypeptides codes par des genes bacteriens essentiels WO2004081206A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/167,924 US20070072192A1 (en) 2002-12-26 2005-06-27 Novel polypeptides encoded by essential bacterial genes

Applications Claiming Priority (62)

Application Number Priority Date Filing Date Title
US45420003P 2003-03-12 2003-03-12
US45389303P 2003-03-12 2003-03-12
US45390103P 2003-03-12 2003-03-12
US60/453,901 2003-03-12
US60/454,200 2003-03-12
US60/453,893 2003-03-12
US45453203P 2003-03-13 2003-03-13
US45449703P 2003-03-13 2003-03-13
US45452103P 2003-03-13 2003-03-13
US45451203P 2003-03-13 2003-03-13
US45449003P 2003-03-13 2003-03-13
US45445903P 2003-03-13 2003-03-13
US45445503P 2003-03-13 2003-03-13
US45446603P 2003-03-13 2003-03-13
US45444703P 2003-03-13 2003-03-13
US45447403P 2003-03-13 2003-03-13
US60/454,532 2003-03-13
US60/454,497 2003-03-13
US60/454,447 2003-03-13
US60/454,512 2003-03-13
US60/454,521 2003-03-13
US60/454,490 2003-03-13
US60/454,455 2003-03-13
US60/454,474 2003-03-13
US60/454,466 2003-03-13
US60/454,459 2003-03-13
US45497703P 2003-03-14 2003-03-14
US45501903P 2003-03-14 2003-03-14
US45500703P 2003-03-14 2003-03-14
US45476903P 2003-03-14 2003-03-14
US45481103P 2003-03-14 2003-03-14
US45478403P 2003-03-14 2003-03-14
US45501403P 2003-03-14 2003-03-14
US45497303P 2003-03-14 2003-03-14
US45503903P 2003-03-14 2003-03-14
US45496903P 2003-03-14 2003-03-14
US45509003P 2003-03-14 2003-03-14
US60/454,784 2003-03-14
US60/454,977 2003-03-14
US60/455,019 2003-03-14
US60/454,811 2003-03-14
US60/455,039 2003-03-14
US60/454,973 2003-03-14
US60/455,090 2003-03-14
US60/454,769 2003-03-14
US60/455,007 2003-03-14
US60/454,969 2003-03-14
US60/455,014 2003-03-14
US45523003P 2003-03-17 2003-03-17
US45519003P 2003-03-17 2003-03-17
US45523903P 2003-03-17 2003-03-17
US45534703P 2003-03-17 2003-03-17
US45535803P 2003-03-17 2003-03-17
US45542903P 2003-03-17 2003-03-17
US45531403P 2003-03-17 2003-03-17
US60/455,190 2003-03-17
US60/455,429 2003-03-17
US60/455,230 2003-03-17
US60/455,358 2003-03-17
US60/455,347 2003-03-17
US60/455,239 2003-03-17
US60/455,314 2003-03-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/167,924 Continuation-In-Part US20070072192A1 (en) 2002-12-26 2005-06-27 Novel polypeptides encoded by essential bacterial genes

Publications (2)

Publication Number Publication Date
WO2004081206A2 WO2004081206A2 (fr) 2004-09-23
WO2004081206A3 true WO2004081206A3 (fr) 2005-03-31

Family

ID=32996758

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2004/000362 WO2004081206A2 (fr) 2002-12-26 2004-03-12 Nouveaux polypeptides codes par des genes bacteriens essentiels

Country Status (1)

Country Link
WO (1) WO2004081206A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2507255A1 (fr) 2009-12-01 2012-10-10 Universita' Degli Studi Di Modena E Reggio Emilia Peptides se liant à l'interface de dimère de la thymidylate synthase pour le traitement du cancer
US9701760B2 (en) 2012-02-13 2017-07-11 National University Corporation Kyoto Institute Of Technology Peptide having affinity for silicon nitride (Si3N4), and use therefor
CN110389147A (zh) * 2018-04-18 2019-10-29 中昊晨光化工研究院有限公司 一种基于核磁共振测定全氟聚醚的结构和分子量的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070955A2 (fr) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification de genes esentiels dans des procaryotes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001070955A2 (fr) * 2000-03-21 2001-09-27 Elitra Pharmaceuticals, Inc. Identification de genes esentiels dans des procaryotes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE UNIPROT [online] 1 November 1995 (1995-11-01), LANGEN ET AL.: "Two-dimensional map of the proteome of Haemophilus influenzae", XP002292463, retrieved from EBI Database accession no. P43874 *
LANGEN H ET AL: "TWO-DIMENSIONAL MAP OF THE PROTEOME OF HAEMOPHILUS INFLUENZAE", ELECTROPHORESIS, WEINHEIM, DE, vol. 2, no. 21, January 2000 (2000-01-01), pages 411 - 429, XP001085261, ISSN: 0173-0835 *
OTTING G: "Experimental NMR techniques for studies of protein-ligand interactions", CURRENT OPINION IN STRUCTURAL BIOLOGY, CURRENT BIOLOGY LTD., LONDON, GB, vol. 3, no. 5, 1993, pages 760 - 768, XP009024400, ISSN: 0959-440X *
WHITTLE P J ET AL: "PROTEIN STRUCTURE-BASED DRUG DESIGN", ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, ANNUAL REVIEWS INC., PALO ALTO, CA, US, vol. 23, 1994, pages 349 - 375, XP001008225, ISSN: 1056-8700 *

Also Published As

Publication number Publication date
WO2004081206A2 (fr) 2004-09-23

Similar Documents

Publication Publication Date Title
AU2001286064A1 (en) Treatment of drug resistant organisms
EP2434016A3 (fr) Expression de proteines mammifères dans Pseudomonas fluorescens
WO2004041854A3 (fr) Nouveaux polypeptides bacteriens essentiels
WO2004099235A3 (fr) Bacteriocines et nouvelles souches bacteriennes
WO2007093848A3 (fr) Nouveaux polypeptides purifiés issus de helicobacter pylori
WO2003087353A3 (fr) Nouveaux polypeptides purifies impliques dans la biogenese membranaire
WO2002068465A3 (fr) Nouvelle proteine pouvant etre induite par p53
WO2005058945A3 (fr) Variants genetiques codant pour des proteines issues de la voie metabolique de produits chimiques fins
EP2392655A3 (fr) Polypeptides de facteur VII à coagulation
WO2004094651A3 (fr) Nouveaux polypeptides humains codes par des polynucleotides
WO2004081206A3 (fr) Nouveaux polypeptides codes par des genes bacteriens essentiels
WO2003102190A3 (fr) Nouveaux polypeptides purifies responsables de la viabilite bacterienne
WO2004058809A3 (fr) Nouveaux polypeptides bacteriens essentiels
AU2003227622A1 (en) Methylthiophene carboxanilides
WO2007064865A3 (fr) Polypeptides fabg purifies intervenant dans la synthese bacterienne d'acides gras
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
MY136784A (en) Global regulators of bacterial pathogenic genes as targets for engineering disease resistance
WO2003025004A3 (fr) Polypeptides purifies intervenant dans le traitement d'acides nucleiques
WO2003027139A3 (fr) Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire
WO2003084987A3 (fr) Nouveaux polypeptides purifies intervenant dans la synthese et la transformation de l'acide nucleique
WO2003084986A3 (fr) Nouveaux polypeptides modifies impliques dans le metabolisme cellulaire
WO2003083099A3 (fr) Nouveaux polypeptides purifies impliques dans la synthese et la modification des proteines
WO2003097789A3 (fr) Nouveaux polypeptides purifies issus de pseudomonas aeruginosa
WO2003035858A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des acides nucleiques
WO2003025008A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement de proteines

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 11167924

Country of ref document: US

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 11167924

Country of ref document: US